Navigation Links
A cost-effective way toward personalized cancer drugs
Date:10/25/2013

This news release is available in German.

Before a cancer patient embarks on a course of treatment, tests can be carried out to establish whether or not the chosen cytostatic agent combination is likely to be effective. But the time-consuming and expensive nature of traditional testing methods is prohibiting their widespread use. Collaborating with DITABIS Digital Biomedical Imaging Systems AG and scientists from Universitts-Frauenklinik Tbingen, Fraunhofer researchers have developed a cost-effective, automated system that allows doctors to determine which medications will prove most benefit for each patient. The "DiagnoSYS" system will be on show at BIOTECHNICA 2013 (Booth E09 in Hall 9), which will take place from October 8-10 in Hannover, Germany.

In treating many types of cancer, doctors often use combi-nation of chemotherapy with other treatments. The cytostatic agents used are designed to target faster growing cancer cells. But there is little consistency in how different patients respond to the various treatments: even when dealing with the same type of tumor, there are vast differences in tumor cell reaction to a given treatment. What greatly helps one person may have little effect on another. Thanks to in vitro chemosensitivity testing, it is possible to find the most effective drug for each patient before commencing treatment. The catch is that current methods of testing are extremely expensive and are not covered by standard health insurance plans, meaning that this personalized approach to treating tumors is rarely put into practice.

"Up till now, these tests have mainly been carried out manually," explains biologist Caroline Siegert from the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. Medical laboratory scientists begin by m
'/>"/>

Contact: Axel Storz
axel.storz@ipa.fraunhofer.de
49-711-970-3660
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Researchers develop rapid, cost-effective early detection method for organ transplant injury
2. Cost-effective: Universal HIV testing in India
3. A new cost-effective genome assembly process
4. Cost-effective production of infrared lenses
5. Towards a real understanding of depression
6. Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find
7. Toward understanding the dangers of the fake marijuana called Spice or K2
8. Insect-inspired super rubber moves toward practical uses in medicine
9. Toward a safer form of acetaminophen
10. New materials, progress toward an HIV vaccine, and more at meeting of crystallographers
11. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A cost-effective way toward personalized cancer drugs
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ( ... Voice Biometrics - Global Strategic Business Report" report to their ... and Voice Biometrics in US$ Thousands by the following Segments: Face ... the US, Canada , Japan ... Middle East & Africa ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... A University of Houston partnership that helped Houston avoid the ... all over the state thanks to an $8.8 million grant ... The Texas Diesel Testing and Research Center at the ... a portable emission testing system and a heavy-duty engine dynamometer, ...
... news for chips lovers everywhere new research in SCIs ... pre-soaking potatoes in water before frying can reduce levels of ... when starch rich foods are cooked at high temperatures, such ... growing concern that acrylamide found in a wide range ...
... March 4 /PRNewswire-FirstCall/,-- Phoenix Technologies Ltd. (Nasdaq: ... ATML ) today announced the integration of ... and SecureCore,Pre-boot Authentication (PBA) products., (Logo: ... design effort between the two industry leaders,provides ...
Cached Biology News:State, UH teaming up to reduce (ob)noxious air emissions 2Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs 2Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs 3Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs 4
(Date:5/6/2015)... --  University of Maryland (UM) Ventures and ... an exclusive option by Biomecite Diagnostics for the rights ... to detect inflammatory bowel diseases (IBD), such as ulcerative ... Fricke and James White developed the ... Maryland School of Medicine,s Institute for Genome Sciences (IGS). ...
(Date:5/6/2015)... May 6, 2015 ... specialist, announced today that it has signed an agreement ... PEIX ) for the delivery of an industrial scale ... the consumption of water, energy and emissions ... This project is fully aligned ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and ... latest major content upgrade to its bestselling, Commercial Off-The-Shelf ... is a significant advancement of FreezerPro® system , ... while also simplifying , New FreezerPro® ... Download available immediately for free to “Gold” support ...
(Date:5/5/2015)... , May 5, 2015  23andMe, Inc., the leading ... Lupus Research Study in collaboration with Pfizer ... systemic lupus erythematosus, more commonly known as lupus, into ... lupus. The effort is also in collaboration with the ... Month in May. Approximately 1.5 million people ...
Breaking Biology Technology:Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2RURO Releases version 7 of FreezerPro® software 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3
... Calif., Jan. 7 Intradigm Corporation, a leading,developer ... that the company has closed the final tranche ... the $2.9 million tranche, with,existing investor, Lilly Ventures, ... the total Series B financing to $21.4 million. ...
... SEATTLE, Jan. 7 Cell Therapeutics, Inc. (CTI),(Nasdaq and ... that,the NASDAQ Listing Qualifications Panel has granted CTI,s request ... NASDAQ Global Market to The NASDAQ,Capital Market, which will ... 8, 2009. CTI,s shares will continue to trade under ...
... Calif., Jan. 6 InterMune, Inc.,(Nasdaq: ITMN ... Executive,Officer and President of InterMune, will present at the ... January 15, 2009 at 1:00 p.m.,PST. , ... the presentation, investors and other,interested parties may log on ...
Cached Biology Technology:Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 2Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 3
... 5 ml of DETACHaBEAD 19 polyclonal ... CD19 (Pan B). B cells ... and released with DETACHaBEAD CD19 are ... suitable for applications such as culturing ...
... supplied as 10X concentrated solutions. REact Buffer SetConsists ... the REact buffers and one 250 microl vial ... 1 ml vials of REact 1 Buffer four ... 1 ml vials of REact 3 Buffer and ...
... Apoptosis Assay Kit #4 detects apoptosis ... in the permeability of cell membranes. This ... and propidium iodide nucleic acid stains. YO-PRO-1 ... of apoptotic cells and labels them with ...
Porcine TNF-alpha/TNFSF1A ELISpot Development Module...
Biology Products: